Analyst Ranking
Bottom 1%
#5257 out of 5279 analysts
Average Return
-10.91%
Win Rate
32%73 out of 226
Risk vs Reward
Poor
Good

Michael Petusky's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Lifecore Biomedical IncLFCR
+131.94%$3.10$7.19
2023-03-20 -
2024-03-19
Buy
Anika Therapeutics IncANIK
+81.95%$8.26$15.02
2025-07-31 -
2026-05-21
Buy
Opko Health IncOPK
+65.31%$0.99$1.63
2024-02-28 -
2025-02-27
Buy
Anika Therapeutics IncANIK
+64.69%$9.12$15.02
2025-09-23 -
2026-05-21
Buy
Anika Therapeutics IncANIK
+57.77%$9.52$15.02
2026-01-09 -
2026-05-21
Buy

Michael Petusky Analyst Color

Get additional color on Michael Petusky's coverage of popular stocks

Michael Petusky's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
U S Physical Therapy IncUSPH
23Buy$90.00+45.26%Maintains
12 days ago
Haemonetics CorpHAE
26Buy$89.00+35.90%Maintains
12 days ago
Lemaitre Vascular IncLMAT
14Buy$120.00+22.76%Maintains
18 days ago
Option Care Health IncOPCH
20Buy$32.00+52.89%Maintains
23 days ago
Lifecore Biomedical IncLFCR
13Buy$6.00+21.70%Maintains
25 days ago
Merit Medical Systems IncMMSI
27Buy$107.00+66.74%Maintains
a month ago
Orthofix Medical IncOFIX
7Buy$17.00+58.14%Maintains
a month ago
Bioventus IncBVS
2Buy$14.00+50.86%Maintains
3 months ago
Opko Health IncOPK
12Buy$1.50+18.11%Maintains
3 months ago
Dentsply Sirona IncXRAY
23Buy$17.00+66.50%Maintains
3 months ago
Anika Therapeutics IncANIK
17Buy$17.00+14.25%Maintains
3 months ago
Henry Schein IncHSIC
19Buy$97.00+30.71%Maintains
3 months ago
Verifyme IncVRME
11Buy$1.50+126.59%Maintains
5 months ago
Modivcare IncMODVQ
13Buy$6.00N/AMaintains
a year ago
Surmodics IncSRDX
5Buy$71.00N/AMaintains
2 years ago
Ati Physical Therapy IncATIP
1Buy$14.00N/AInitiates Coverage On
5 years ago
Pharmerica CorpPMC
1SellN/AN/ADowngrades
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.